Results may vary. Actual vial appearance, contents, and dosage may vary and is based on your prescription. View full disclaimer in footer.*
FDA-studied GHRH analog for visceral fat reduction and growth hormone optimization.
$229/ month
Includes provider consult, prescription, and shipping.
Tesamorelin is a stabilized analog of growth hormone-releasing hormone (GHRH) that has been studied in FDA clinical trials for visceral adiposity reduction. It stimulates pulsatile GH release, supporting fat metabolism — particularly visceral fat — while also improving body composition, cognitive function, and metabolic markers.
*Price shown applies to 6-Month plan paid upfront or with buy now, pay later programs. Actual price will depend on product and plan prescribed.
**The FDA does not review or approve any compounded medications for safety or effectiveness.
Compounded medications are not FDA-approved drugs. They are prepared by licensed compounding pharmacies based on a clinician's prescription for an individual patient. Individual results vary. A medical evaluation is required to determine if this therapy is appropriate for you. Some uses discussed may be considered off-label. The FDA does not review or approve any compounded medications for safety or effectiveness.